academic article

• Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model..  American journal of hematology.  86:155-162. 2011
• Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10..  Clinical immunology (Orlando, Fla.).  126:211-221. 2008
• Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production..  The Journal of infectious diseases.  198:1219-1226. 2008
• Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria..  The American journal of tropical medicine and hygiene.  76:1033-1036. 2007
• Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia..  Infection and immunity.  75:201-210. 2007
• Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria..  Clinical immunology (Orlando, Fla.).  119:219-225. 2006
• Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria..  Infection and immunity.  73:4190-4197. 2005
• MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia..  The Journal of infectious diseases.  200:629-637.
• Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism..  Microbes and infection / Institut Pasteur.  11:811-819.
• Suppression of a novel hematopoietic mediator in children with severe malarial anemia..  Infection and immunity.  77:3864-3871.